ZA200702317B - Methods for preparing indazole compounds - Google Patents
Methods for preparing indazole compoundsInfo
- Publication number
- ZA200702317B ZA200702317B ZA200702317A ZA200702317A ZA200702317B ZA 200702317 B ZA200702317 B ZA 200702317B ZA 200702317 A ZA200702317 A ZA 200702317A ZA 200702317 A ZA200702317 A ZA 200702317A ZA 200702317 B ZA200702317 B ZA 200702317B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- indazole compounds
- preparing indazole
- preparing
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62457504P | 2004-11-02 | 2004-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200702317B true ZA200702317B (en) | 2008-09-25 |
Family
ID=35528034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200702317A ZA200702317B (en) | 2004-11-02 | 2007-03-20 | Methods for preparing indazole compounds |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1809625A1 (en) |
| JP (1) | JP2008518901A (en) |
| KR (1) | KR20070058689A (en) |
| CN (1) | CN101044138A (en) |
| AR (1) | AR051753A1 (en) |
| AU (1) | AU2005300311A1 (en) |
| BR (1) | BRPI0517921A (en) |
| CA (1) | CA2586176A1 (en) |
| IL (1) | IL182096A0 (en) |
| MX (1) | MX2007003603A (en) |
| NO (1) | NO20072747L (en) |
| RU (1) | RU2007114112A (en) |
| TW (1) | TW200614990A (en) |
| WO (1) | WO2006048745A1 (en) |
| ZA (1) | ZA200702317B (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008044045A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
| JP5528806B2 (en) | 2006-10-12 | 2014-06-25 | アステックス、セラピューティックス、リミテッド | Compound drug |
| FI2134702T4 (en) | 2007-04-05 | 2023-09-12 | Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole suitable for the treatment of abnormal cell growth in mammals | |
| US8354528B2 (en) * | 2007-10-25 | 2013-01-15 | Genentech, Inc. | Process for making thienopyrimidine compounds |
| EP2163544A1 (en) * | 2008-09-16 | 2010-03-17 | Pfizer, Inc. | Methods of preparing indazole compounds |
| TW201328725A (en) | 2011-09-30 | 2013-07-16 | Pfizer | Pharmaceutical compositions of N-methyl-2-3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl-benzamide |
| MX2014005715A (en) | 2011-11-11 | 2014-05-28 | Pfizer | N-methyl-2-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indazol-6-ylsulfanyl ]-benzamide for the treatment of chronic myelogenous leukemia. |
| EP2792360A1 (en) | 2013-04-18 | 2014-10-22 | IP Gesellschaft für Management mbH | (1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV |
| CN103387565B (en) * | 2013-07-29 | 2014-10-29 | 苏州明锐医药科技有限公司 | Preparation method of Axitinib |
| CN103570696B (en) * | 2013-11-06 | 2016-02-24 | 湖南欧亚生物有限公司 | A kind of preparation method of Axitinib intermediate and preparing the application in Axitinib |
| WO2015067224A1 (en) | 2013-11-08 | 2015-05-14 | Zentiva, K.S. | Salts of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethanyl] indazole |
| ES2710211T3 (en) | 2014-02-04 | 2019-04-23 | Pfizer | Combination of a PD-1 antagonist and a VEGFR inhibitor to treat cancer |
| ES2647262T3 (en) * | 2014-03-31 | 2017-12-20 | Senju Pharmaceutical Co. Ltd | Alkynyl indazole derivative and use thereof |
| CN104072484B (en) * | 2014-07-07 | 2016-07-06 | 渤海大学 | Nitrogen-(4-(aromatic thiohydroxy)-1 hydrogen-indazole-3-base)-1-(heteroaromatic replacement) methylene imine compounds and pharmaceutically acceptable salt and its preparation method and application thereof |
| JP2017530950A (en) | 2014-08-25 | 2017-10-19 | ファイザー・インコーポレイテッド | Combination of PD-1 antagonist and ALK inhibitor for treating cancer |
| WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| RU2714233C2 (en) | 2015-02-26 | 2020-02-13 | Мерк Патент Гмбх | Pd-1/pd-l1 inhibitors for treating cancer |
| US9580406B2 (en) | 2015-04-28 | 2017-02-28 | Signa S.A. De C.V. | Processes for the preparation of axitinib |
| CA2989586A1 (en) | 2015-06-16 | 2016-12-22 | Pfizer, Inc. | Pd-l1 antagonist combination treatments |
| KR20190062515A (en) | 2016-10-06 | 2019-06-05 | 화이자 인코포레이티드 | Usage of Abelipab for the Treatment of Cancer |
| WO2020128893A1 (en) | 2018-12-21 | 2020-06-25 | Pfizer Inc. | Combination treatments of cancer comprising a tlr agonist |
| US20220194921A1 (en) | 2019-04-18 | 2022-06-23 | Synthon B.V. | Process for preparation of axitinib |
| CN112209861A (en) * | 2019-07-11 | 2021-01-12 | 鲁南制药集团股份有限公司 | Acixtinib intermediate compound and preparation method thereof |
| CN112442010B (en) * | 2019-08-30 | 2023-10-03 | 润佳（苏州）医药科技有限公司 | Prodrug compounds and application thereof in treating cancers |
| CN111440102B (en) * | 2020-04-26 | 2022-02-15 | 大连凯飞化学股份有限公司 | Preparation method of dithiodibenzoamide compound |
| WO2023166420A1 (en) | 2022-03-03 | 2023-09-07 | Pfizer Inc. | Multispecific antibodies and uses thereof |
| CN114591338B (en) * | 2022-03-31 | 2023-05-09 | 苏州欧康维视生物科技有限公司 | Preparation method and application of Syk and VEGFR2 double-target inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20010306A1 (en) * | 1999-07-02 | 2001-03-29 | Agouron Pharma | INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM USEFUL FOR THE INHIBITION OF PROTEIN KINASE |
| CN1747950A (en) * | 2002-12-19 | 2006-03-15 | 美国辉瑞有限公司 | 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| EP1606283B1 (en) * | 2003-03-03 | 2008-10-08 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| WO2005094823A1 (en) * | 2004-03-30 | 2005-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Flt-3 INHIBITOR |
-
2005
- 2005-10-21 KR KR1020077009804A patent/KR20070058689A/en not_active Application Discontinuation
- 2005-10-21 AU AU2005300311A patent/AU2005300311A1/en not_active Abandoned
- 2005-10-21 CA CA002586176A patent/CA2586176A1/en not_active Abandoned
- 2005-10-21 CN CNA2005800361530A patent/CN101044138A/en active Pending
- 2005-10-21 MX MX2007003603A patent/MX2007003603A/en unknown
- 2005-10-21 WO PCT/IB2005/003300 patent/WO2006048745A1/en active Application Filing
- 2005-10-21 RU RU2007114112/04A patent/RU2007114112A/en not_active Application Discontinuation
- 2005-10-21 EP EP05796299A patent/EP1809625A1/en not_active Withdrawn
- 2005-10-21 BR BRPI0517921-1A patent/BRPI0517921A/en not_active IP Right Cessation
- 2005-10-21 JP JP2007538538A patent/JP2008518901A/en not_active Withdrawn
- 2005-11-01 AR ARP050104567A patent/AR051753A1/en not_active Application Discontinuation
- 2005-11-01 TW TW094138224A patent/TW200614990A/en unknown
-
2007
- 2007-03-20 ZA ZA200702317A patent/ZA200702317B/en unknown
- 2007-03-21 IL IL182096A patent/IL182096A0/en unknown
- 2007-05-30 NO NO20072747A patent/NO20072747L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005300311A1 (en) | 2006-05-11 |
| CA2586176A1 (en) | 2006-05-11 |
| NO20072747L (en) | 2007-07-31 |
| EP1809625A1 (en) | 2007-07-25 |
| JP2008518901A (en) | 2008-06-05 |
| KR20070058689A (en) | 2007-06-08 |
| MX2007003603A (en) | 2007-05-21 |
| IL182096A0 (en) | 2007-07-24 |
| BRPI0517921A (en) | 2008-10-21 |
| AR051753A1 (en) | 2007-02-07 |
| TW200614990A (en) | 2006-05-16 |
| RU2007114112A (en) | 2008-12-10 |
| WO2006048745A1 (en) | 2006-05-11 |
| CN101044138A (en) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182096A0 (en) | Methods for preparing indazole compounds | |
| ZA200704350B (en) | Methods for preparing indazole compounds | |
| IL182693A0 (en) | Methods of preparing indazole compounds | |
| IL183091A0 (en) | Method for preparing n-phenylpyrazole-1-carboxyamides | |
| ZA200702977B (en) | Methods of preparing indazole compounds | |
| IL188600A0 (en) | Method for preparing esomeprazole | |
| TW200619222A (en) | Method for making organometallic compounds | |
| ZA200704535B (en) | Process for preparing rosuvastatin | |
| EP2001480A4 (en) | Indazole compounds | |
| EP1813677A4 (en) | Process for producing basic substance | |
| EP1828170A4 (en) | Process for preparing voriconazole | |
| IL178071A0 (en) | Process for preparing pyridazinone compounds | |
| EP2091329A4 (en) | Indazole compounds | |
| ZA200608083B (en) | Process for preparing 5-methyl-2-furfural | |
| TWI372145B (en) | Process for preparing alkylanilides | |
| EP1751123A4 (en) | Process for preparing irbesartan | |
| IL178069A0 (en) | Process for preparing n-aryl-piperazine derivatives | |
| IL208214A0 (en) | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds | |
| PL1711302T3 (en) | Method for connecting components | |
| EP2147916A4 (en) | Method for the preparation of synthesized taxanoids | |
| IL189574A0 (en) | Process for preparing 1-substituted-5-acylimidazole compounds | |
| HU0400305D0 (en) | Set for spine-fixture | |
| HUP0501174A2 (en) | Apparatus for introducing organwind | |
| EP1713796A4 (en) | Process for preparing substituted benzopyran compounds | |
| IL183804A0 (en) | Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes |